Snorting Wellbutrin (Bupropion) — The Risks, The Reality, and What It Means for Treatment

Wellbutrin (bupropion) is one of the most commonly misused non-controlled prescription medications — and one of the most dangerous to snort. The pharmacological consequences of intranasal bupropion are disproportionately severe: seizure risk, cardiovascular effects, and psychosis occur at dramatically higher rates with insufflation than with oral administration. This page covers what snorting Wellbutrin does, why people do it, the specific dangers, and what it means clinically when someone is misusing bupropion.

What Wellbutrin Actually Is — Why It Gets Misused

Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI) — prescribed primarily as an antidepressant (Wellbutrin) and as a smoking cessation aid (Zyban). Unlike most antidepressants, bupropion does not significantly affect serotonin. Its dopaminergic and noradrenergic activity is what makes it clinically useful for depression and smoking cessation — and also what makes it a target for misuse among people seeking stimulant-like effects.

Oral bupropion, taken as prescribed, has a relatively slow absorption curve — particularly in the extended-release formulations that are the most common prescription. The slow absorption limits dopamine surge magnitude and minimizes euphoria. Snorting bupropion — crushing tablets and insufflating the powder — bypasses this slow-release mechanism entirely. The nasal mucosa absorbs the drug rapidly into the bloodstream, producing a faster, larger dopamine surge that bears some resemblance to the effects of cocaine or amphetamine. This is why intranasal bupropion misuse occurs — but the analogy to other stimulant insufflation dramatically understates the specific dangers of bupropion through this route.

The Specific Dangers of Snorting Wellbutrin

Seizure Risk — Far Higher Than Oral Use

Bupropion lowers the seizure threshold — this is a known and labeled risk even with oral therapeutic dosing, which is why the maximum recommended daily oral dose is 450mg and doses above 150mg are typically split. The seizure risk with oral bupropion at therapeutic doses is approximately 0.1% to 0.4% — rare, but present. With intranasal misuse, particularly with higher doses or extended-release formulations, the seizure risk is dramatically elevated. Case series and emergency department data document bupropion-induced generalized tonic-clonic seizures after intranasal misuse at doses that would not produce seizures with oral administration. The seizure risk is not theoretical — it is documented, it is disproportionate to other stimulant insufflation, and it is life-threatening without emergency intervention.

Cardiovascular Effects

Bupropion elevates both heart rate and blood pressure through its noradrenergic effects. With intranasal administration, the rapid, large-dose delivery produces more acute cardiovascular stimulation than oral use. Palpitations, tachycardia, and elevated blood pressure are common. In individuals with pre-existing cardiovascular vulnerabilities, the cardiovascular consequences of intranasal bupropion can be clinically serious.

Psychosis and Psychiatric Destabilization

Bupropion can cause psychosis at high doses or in vulnerable individuals — this is documented with oral overdose and is significantly more likely with intranasal administration at high-dose exposures. Paranoia, hallucinations (auditory and visual), and agitation have been reported in emergency case reports of bupropion insufflation. For individuals with any personal or family history of psychotic disorders, intranasal bupropion is a particularly significant trigger risk.

Nasal Tissue Damage

Bupropion tablets — particularly extended-release formulations — contain significant amounts of tablet binder, filler, and coating materials that are not absorbed through nasal mucosa. These particulates accumulate in and damage nasal tissue: chronic insufflation produces nasal inflammation, septum erosion, impaired olfactory function, and in severe cases, septal perforation. The nasal damage from snorting Wellbutrin accumulates with repeated use and in many cases is not reversible.

What It Means Clinically When Someone Is Snorting Wellbutrin

Bupropion misuse through the intranasal route typically indicates one of several clinical situations: stimulant use disorder being managed with an available prescription (bupropion as a lower-risk-appearing substitute for cocaine or methamphetamine), polydrug use where bupropion is combined with other substances, or genuine addiction to bupropion itself (less common but documented). The treatment implications depend on which is true — and a clinical assessment is the appropriate way to determine that.

If you are in a carceral setting, jail, or prison — where bupropion has become one of the most commonly misused medications precisely because it is one of the few psychoactive medications that remains available to incarcerated individuals — the clinical picture is additionally complex. We see clients who developed bupropion misuse in correctional settings and who continue it upon release. Assessment and treatment are available.

Treatment for Stimulant-Pattern Bupropion Misuse

There is no specific medication for bupropion use disorder. The clinical approach mirrors stimulant use disorder treatment: CBT targeting the cognitive patterns and environmental triggers driving use, contingency management for verified abstinence, dual diagnosis treatment for the depression or anxiety that frequently underlies stimulant-pattern misuse, and PHP or IOP structure during the high-risk early recovery period. If underlying stimulant use disorder (cocaine, meth) is the primary condition and bupropion has been used as a substitute, treatment targets the primary stimulant use disorder directly.

Frequently Asked Questions — Snorting Wellbutrin